4
Changes in Ownership
BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-21-007642
Senior VP - CMO sold 41,250 shares at $11.57 ($477,263)
- Senior VP - CMO acquired 41,250 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Sheridan William P · Senior VP - CMO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-02-22 | Exercise or conversion : show line 1 in the form | +41,250 | $4.15 | $171,188 | 52,725 | D |
| 2021-02-22 | Sale : show line 2 in the form | −41,250 | $11.57 | $477,263 | 11,475 | D |
| Open-market sales · 41,250 sh · avg $11.57 · $477,263 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-02-22 | Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) | −41,250 | 0 | D |
Loading xslF345X03/form4.xml…